These findings shed light on a new mechanism involving lncRNA H19 in breast cancer tumorigenesis and metastasis, highlighting the H19/p53/TNFAIP8 axis as a potential therapeutic target, especially for TNBC. This evidence concerns the gene H19 and breast cancer.